Walgreens sues CVS, Rite Aid, Shopko for mobile prescription technology infringment

Walgreen Co. (NYSE: WAG) has filed suit against CVS Caremark (NYSE: CVS), Rite Aid (NYSE: RAD) and Shopko Stores, claiming the rival retailers are misappropriating technology for mobile prescription refills and scanning.

Walgreens filed the lawsuits on Friday in U.S. District Court in Delaware. Mobile pharmacy technology provider mscripts LLC is also named in the suit against Shopko.

The Deerfield, Ill.-based retailer charges its competitors with violating its "refill by scan" functionality covered by a Walgreens-held U.S. Patent. Walgreens said the patent was issued on Jan. 7. Refill by scan lets mobile users order refills by scanning a prescription bar code with their mobile device.

Walgreens said it owns, offers and operates mobile apps for iPad, iPhone, Windows Phone, Android and BlackBerry devices that include the refill scanning capability protected by the patent. It claims the named parties are using the technology without a license.

Walgreens seeks unspecified damages from CVS, Rite Aid, Shopko and mscripts and a court order to stop them from using the patent-protected technology.

"We are investigating this matter and cannot comment further on pending litigation," Michael DeAngelis, a spokesman for Woonsocket, Rhode Island-based CVS, told Bloomberg in an emailed statement. Ashley Flower, a spokeswoman for Camp Hill, Pennsylvania-based Rite Aid declined to comment and a spokeswoman for Green Bay, Wisconsin-based Shopko, didn't immediately respond to the news agency's requests for comment.

For more:
-See this Bloomberg article

Related stories:
CVS, Walgreens, Rite Aid offer prescription relief to newly-insured patients
Walgreens' new prescription text service is fast and pointless
Walgreens, Rite Aid post strong quarterly earnings
Walgreens November sales increase 4%
Walgreens, CVS report strong third quarter earnings